Immunosenescence

  1. immunosenescenceย of ageing
  2. immunosenescence
  3. Inflammโ€aging: an evolutionary perspective onย immunosenescence
  4. immunosenescence: emerging challenges for an ageing population
  5. Mechanisms ofย immunosenescence
  6. Humanย immunosenescence: is it infectious?
  7. Isย immunosenescenceย infectious?
  8. immunosenescenceย and infectious diseases
  9. An evolutionary perspective on the mechanisms ofย immunosenescence
  10. immunosenescence: a review
  11. Understandingย immunosenescenceย to improve responses to vaccines
  12. HIV infection, inflammation,ย immunosenescence, and aging
  13. immunosenescenceย and inflamm-aging as two sides of the same coin: friends or foes?
  14. immunosenescenceย and cancer
  15. Factors that may impact onย immunosenescence: an appraisal
  16. Oxidative stress, inflamm-aging andย immunosenescence
  17. immunosenescenceย and HIV
  18. Moderate exercise may attenuate some aspects ofย immunosenescence
  19. Age and immunity: what is โ€œimmunosenescenceโ€?
  20. Potential role ofย immunosenescenceย in cancer development
  21. immunosenescence: what does it mean to health outcomes in older adults?
  22. immunosenescenceย and cancer
  23. Innate and adaptiveย immunosenescence
  24. immunosenescenceย and vaccine failure in the elderly
  25. Cytomegalovirus and humanย immunosenescence
  26. Immunoproteasomes andย immunosenescence
  27. The role ofย immunosenescenceย in the development of age-related diseases
  28. immunosenescenceย and human vaccine immune responses
  29. New advances in CMV andย immunosenescence
  30. CMV andย immunosenescence: from basics to clinics
  31. Rheumatoid arthritis: a role forย immunosenescence?
  32. Human innateย immunosenescence: causes and consequences for immunity in old age
  33. immunosenescenceย and cancer
  34. immunosenescence: implications for response to infection and vaccination in older people
  35. The cellular and subcellular bases ofย immunosenescence
  36. The impact ofย immunosenescenceย on pulmonary disease
  37. immunosenescence: deficits in adaptive immunity in the elderly
  38. immunosenescence: influenza vaccination and the elderly
  39. Social reversal ofย immunosenescenceย in honey bee workers
  40. Hallmarks of human โ€œimmunosenescenceโ€: adaptation or dysregulation?
  41. The role ofย immunosenescenceย in neurodegenerative diseases
  42. immunosenescenceย and its hallmarks: how to oppose aging strategically? A review of potential options for therapeutic intervention
  43. immunosenescenceย and lymphomagenesis
  44. Biomarkers of humanย immunosenescence: impact of Cytomegalovirus infection
  45. Humanย immunosenescence: the prevailing of innate immunity, the failing of clonotypic immunity, and the filling of immunological space
  46. The humanย immunosenescenceย phenotype: does it exist?
  47. Ageing,ย immunosenescenceย and inflammageing in the dog and cat
  48. T-cellย immunosenescence: lessons learned from mouse models of aging
  49. Chronic stress andย immunosenescence: a review
  50. immunosenescenceย in aging: between immune cells depletion and cytokines up-regulation
  51. immunosenescence: role and measurement in influenza vaccine response among the elderly
  52. immunosenescenceย of human natural killer cells
  53. immunosenescenceย in wild animals: metaโ€analysis and outlook
  54. The untwining ofย immunosenescenceย and aging
  55. Cytometric analysis ofย immunosenescence
  56. immunosenescenceย and novel vaccination strategies for the elderly
  57. Hallmark features ofย immunosenescenceย are absent in familial longevity
  58. Can physical activity ameliorateย immunosenescenceย and thereby reduce age-related multi-morbidity?
  59. Sepsis andย immunosenescenceย in the elderly patient: a review
  60. Nutrition, diet andย immunosenescence
  61. immunosenescenceย and germinal center reaction
  62. Zinc homeostasis andย immunosenescence
  63. Isย immunosenescenceย influenced by our lifetime โ€œdoseโ€ of exercise?
  64. Zinc, aging, andย immunosenescence: an overview
  65. Human T cellย immunosenescenceย and inflammation in aging
  66. immunosenescence: ageing of the immune system
  67. Basic biology and clinical impact ofย immunosenescence
  68. Reversing age-associatedย immunosenescenceย via exercise
  69. Reversing T cellย immunosenescence: why, who, and how
  70. immunosenescence: a product of the environment?
  71. immunosenescence, autoimmunity, and rheumatoid arthritis
  72. immunosenescenceย of polymorphonuclear neutrophils
  73. COPD as a Disease ofย immunosenescence
  74. Aging, persistent viral infections, andย immunosenescence: can exerciseโ€ make spaceโ€?
  75. immunosenescenceย in vertebrates and invertebrates
  76. B Cellย immunosenescence
  77. A systems biology approach to the effect of aging,ย immunosenescenceย and vaccine response
  78. immunosenescenceย and immunogenetics of human longevity
  79. HIV as a cause of immune activation andย immunosenescence
  80. NK and NKT cell functions inย immunosenescence
  81. immunosenescence: a systems-level overview of immune cell biology and strategies for improving vaccine responses
  82. immunosenescence: implications for vaccination programmes in adults
  83. Biomarkers ofย immunosenescenceย within an evolutionary perspective: the challenge of heterogeneity and the role of antigenic load
  84. Cytokines and hormones as possible links between endocrinosenescence andย immunosenescence
  85. Cytomegalovirus infection: a driving force in human T cellย immunosenescence
  86. The role of the thymus inย immunosenescence: lessons from the study of thymectomized individuals
  87. Complexity of antiโ€immunosenescenceย strategies in humans
  88. Innateย immunosenescence: effect of aging on cells and receptors of the innate immune system in humans
  89. Aging with HIV infection: a journey to the center of inflammAIDS,ย immunosenescenceย and neuroHIV
  90. immunosenescenceย and vaccine failure in the elderly: strategies for improving response
  91. Mechanisms underlying T cellย immunosenescence: aging and cytomegalovirus infection
  92. Mechanisms ofย immunosenescence-lessons from models of accelerated immune aging
  93. immunosenescenceย and immunecheckpoint inhibitors in non-small cell lung cancer patients: does age really matter?
  94. immunosenescence, inflammation and Alzheimerโ€™s disease
  95. immunosenescenceย and challenges of vaccination against influenza in the aging population
  96. Mucosalย immunosenescence: new developments and vaccines to control infectious diseases
  97. Probiotics andย immunosenescence: cheese as a carrier
  98. immunosenescenceย and aging in HIV
  99. immunosenescenceย exacerbates the COVID-19
  100. Remodeling of the immune response with aging:ย immunosenescenceย and its potential impact on COVID-19 immune response
  101. immunosenescenceย and influenza vaccine efficacy
  102. immunosenescenceย and Cytomegalovirus: where do we stand after a decade?
  103. Impact ofย immunosenescenceย on transplant outcome
  104. Frailty, inflammation andย immunosenescence
  105. Decline in CD28+ T cells in centenarians and in long-term T cell cultures: a possible cause for both in vivo and in vitroย immunosenescence
  106. Stress andย immunosenescence: The role of telomerase
  107. Oxidative stress andย immunosenescence: therapeutic effects of melatonin
  108. Humanย immunosenescence: does it have an infectious component?
  109. Human cytomegalovirus infection and T cellย immunosenescence: a mini review
  110. immunosenescenceย of microglia and macrophages: impact on the ageing central nervous system
  111. Aging and the immune system: the impact ofย immunosenescenceย on viral infection, immunity and vaccine immunogenicity
  112. The role of oxidative and inflammatory stress and persistent viral infections inย immunosenescence
  113. immunosenescenceย and inflammation characterize chronic heart failure patients with more advanced disease
  114. immunosenescence, aging, and systemic lupus erythematous
  115. Herpes zoster pathogenesis and cell-mediated immunity andย immunosenescence
  116. immunosenescence: the potential role of myeloid-derived suppressor cells (MDSC) in age-related immune deficiency
  117. Effects of physical exercise on markers of cellularย immunosenescence: a systematic review
  118. The interplay betweenย immunosenescenceย and age-related diseases
  119. Contributions of age-related thymic involution toย immunosenescenceย and inflammaging
  120. Prematureย immunosenescenceย in rheumatoid arthritis and multiple sclerosis patients
  121. A study of serum immunoglobulin levels in elderly persons that provides new insights into B cellย immunosenescence
  122. Rheumatoid arthritis,ย immunosenescenceย and the hallmarks of aging
  123. immunosenescenceย of macrophages: reduced MHC class II gene expression
  124. Molecular and cellular basis ofย immunosenescence
  125. โ€ฆ infection, enhanced proinflammatory response and low level of anti-hemagglutinins during the anti-influenza vaccinationโ€”an impact ofย immunosenescence
  126. Frailty and the role of inflammation,ย immunosenescenceย and cellular ageing in the very old: cross-sectional findings from the Newcastle 85+ Study
  127. Zinc, infections andย immunosenescence
  128. Leptin inducesย immunosenescenceย in human B cells
  129. The impact of the microbiome onย immunosenescence
  130. Mitochondria,ย immunosenescenceย and inflammaging: a role for mitokines?
  131. Reversingย immunosenescenceย for prevention of COVID-19
  132. immunosenescenceย and pneumococcal disease: an imbalance in hostโ€“pathogen interactions
  133. Helminth infections andย immunosenescence: The friend of my enemy
  134. Cell therapy strategies to combatย immunosenescence
  135. immunosenescenceย and organ transplantation
  136. Handbook ofย immunosenescence
  137. Nutrition and fasting mimicking diets in the prevention and treatment of autoimmune diseases andย immunosenescence
  138. The role of DNA methylation and hydroxymethylation inย immunosenescence
  139. Biomarkers related toย immunosenescence: relationships with therapy and survival in lung cancer patients
  140. A decline in p38 MAPK signaling underliesย immunosenescenceย in Caenorhabditis elegans
  141. immunosenescenceย and macrophage functional plasticity: dysregulation of macrophage function by ageโ€associated microenvironmental changes
  142. immunosenescenceย and cancer: a review
  143. immunosenescenceย of natural killer cells, inflammation, and Alzheimerโ€™s disease
  144. Intracellular signalling pathways: targets to reverseย immunosenescence
  145. An association betweenย immunosenescenceย and CD4+ CD25+ regulatory T cells: a systematic review
  146. The impact of senescence-associated T cells onย immunosenescenceย and age-related disorders
  147. Rudimentary signs ofย immunosenescenceย in Cytomegalovirus-seropositive healthy young adults
  148. Cytomegalovirus persistence and T-cellย immunosenescenceย in people aged fifty and older: a systematic review
  149. immunosenescenceย is both functional/adaptive and dysfunctional/maladaptive
  150. immunosenescenceย patterns differ between populations but not between sexes in a long-lived mammal
  151. Sex, gender andย immunosenescence: a key to understand the different lifespan between men and women?
  152. immunosenescenceย in some but not all immune components in a free-living vertebrate, the tree swallow
  153. Cell-mediatedย immunosenescenceย in birds
  154. Role of CD8 T cell replicative senescence in human aging and in HIV-mediatedย immunosenescence
  155. Preventing or reversingย immunosenescence: can exercise be an immunotherapy?
  156. Cellular senescence,ย immunosenescenceย and HIV
  157. Immunological pathogenesis of main age-related diseases and frailty: role ofย immunosenescence
  158. Mucosalย immunosenescenceย in the gastrointestinal tract: a mini-review
  159. Down syndrome, accelerated aging andย immunosenescence
  160. Fighting against a protean enemy:ย immunosenescence, vaccines, and healthy aging
  161. The role of pulmonary and systemicย immunosenescenceย in acute lung injury
  162. CD4+ CD25+ T regulatory cells inhibit cytotoxic activity of CTL and NK cells in humansโ€”impact ofย immunosenescence
  163. immunosenescenceย comes of age: symposium on aging research in immunology: the impact of genomics
  164. The Interplay betweenย immunosenescenceย and Microbiota in the Efficacy of Vaccines
  165. The Nlrp3 inflammasome promotes age-related thymic demise andย immunosenescence
  166. immunosenescenceย and vaccination in nursing home residents
  167. Is humanย immunosenescenceย clinically relevant? Looking for โ€˜immunological risk phenotypesโ€™
  168. A model of premature aging in mice based on altered stress-related behavioral response andย immunosenescence
  169. The unmet need in the elderly: howย immunosenescence, CMV infection, co-morbidities and frailty are a challenge for the development of more effective influenza โ€ฆ
  170. Features ofย immunosenescenceย in women newly diagnosed with breast cancer
  171. Leukocyte function and life span in a murine model of prematureย immunosenescence
  172. immunosenescenceย in monocytes, macrophages, and dendritic cells: lessons learned from the lung and heart
  173. B cellย immunosenescence: different features of naive and memory B cells in elderly
  174. Inflammation and neutrophilย immunosenescenceย in health and disease: Targeted treatments to improve clinical outcomes in the elderly
  175. immunosenescenceย in HIV pathogenesis
  176. A Perspective on Roles Played byย immunosenescenceย in the Pathobiology of Alzheimerโ€™s Disease
  177. immunosenescence-related transcriptomic and immunologic changes in older individuals following influenza vaccination
  178. immunosenescenceโ€associated microRNAs in age and heart failure
  179. Relation of behaviour and macrophage function to life span in a murine model of prematureย immunosenescence
  180. T cellย immunosenescenceย after early life adversity: association with cytomegalovirus infection
  181. immunosenescence: the role of aging in the predisposition to neuro-infectious complications arising from the treatment of multiple sclerosis
  182. immunosenescenceย and immune response in organ transplantation
  183. T cellย immunosenescenceย in vitro and in vivo
  184. immunosenescence.
  185. Multiple myeloma causes clonal T-cellย immunosenescence: identification of potential novel targets for promoting tumour immunity and implications for checkpoint โ€ฆ
  186. Immune Cells andย immunosenescence
  187. Caloric restriction andย immunosenescence: a current perspective
  188. โ€ฆ of the potential implications of polyphenols in influencing the interrelationship between oxi-inflammatory stress, cellular senescence andย immunosenescenceย during โ€ฆ
  189. Behavioral characterization of a mouse model of prematureย immunosenescence
  190. Psychoneuroendocrine interventions aimed at attenuatingย immunosenescence: a review
  191. Tumor-derived ฮณฮด regulatory T cells suppress innate and adaptive immunity through the induction ofย immunosenescence
  192. A case of progressive multifocal leukoencephalopathy under dimethyl fumarate treatment without severe lymphopenia orย immunosenescence
  193. Ageing and myeloid-derived suppressor cells: possible involvement inย immunosenescenceย and age-related disease
  194. Aging-associatedย immunosenescenceย via alterations in splenic immune cell populations in rat
  195. The impact ofย immunosenescenceย on humoral immune response variation after influenza A/H1N1 vaccination in older subjects
  196. Unraveling the molecular mechanism ofย immunosenescenceย in Drosophila
  197. Peripheralย immunosenescenceย and Central Neuroinflammation: A Dangerous Liaison-A Dietary Approach
  198. immunosenescenceย and age-related viral diseases
  199. Modulation of gut microbiota and delayedย immunosenescenceย as a result of syringaresinol consumption in middle-aged mice
  200. T-cellย immunosenescenceย and inflammatory response in atomic bomb survivors
  201. Diabetic gut microbiota dysbiosis as an inflammaging andย immunosenescenceย condition that fosters progression of retinopathy and nephropathy
  202. immunosenescenceย is associated with presence of Kaposiโ€™s sarcoma in antiretroviral treated HIV infection
  203. immunosenescence: limitations of natural killer cell-based cancer immunotherapy
  204. Successfulย immunosenescenceย and the remodelling of immune responses with ageing
  205. Age related changes in population of peripheral T cells: towards a model ofย immunosenescence
  206. Acceleratedย immunosenescenceย in rheumatoid arthritis: impact on clinical progression
  207. immunosenescence, suppression and tumour progression
  208. Chemotherapy-induced changes andย immunosenescenceย of CD8+ T-cells in patients with breast cancer
  209. immunosenescenceย and rheumatoid arthritis: does telomere shortening predict impending disease?
  210. Apoptosis remodeling inย immunosenescence: implications for strategies to delay ageing
  211. B cells andย immunosenescence: a focus on IgG+ IgDโˆ’ CD27โˆ’(DN) B cells in aged humans
  212. CD4+ T cells andย immunosenescenceโ€“a mini-review
  213. 5th International Workshop on CMV andย immunosenescence: a shadow of cytomegalovirus infection on immunological memory
  214. Consequences of immune system aging in nature: a study ofย immunosenescenceย costs in freeโ€living Tree Swallows
  215. Are skin senescence andย immunosenescenceย linked within individuals?
  216. T-cellย immunosenescenceย and its clinical relevance in man
  217. The impact ofย immunosenescenceย on the efficacy of immune checkpoint inhibitors in melanoma patients: a meta-analysis
  218. Cytomegalovirus (CMV) research in immune senescence comes of age: overview of the 6th International Workshop on CMV andย immunosenescence
  219. immunosenescenceย and resistance to parasite infection in the honey bee, Apis mellifera
  220. Senescent endothelial cells: potential modulators ofย immunosenescenceย and ageing
  221. Immunologic mechanisms of fingolimod and the role ofย immunosenescenceย in the risk of cryptococcal infection: a case report and review of literature
  222. Glutathione depletion inhibits dendritic cell maturation and delayed-type hypersensitivity: implications for systemic disease andย immunosenescence
  223. Does regular exercise counter T cellย immunosenescenceย reducing the risk of developing cancer and promoting successful treatment of malignancies?
  224. Early-onset Evans syndrome, immunodeficiency, and prematureย immunosenescenceย associated with tripeptidyl-peptidase II deficiency
  225. immunosenescenceย is associated with human cytomegalovirus and shortened telomeres in type I bipolar disorder
  226. Chronic antigenic load and apoptosis inย immunosenescence
  227. Human Tโ€cell clones in longโ€term culture as a model ofย immunosenescence
  228. immunosenescenceย of the equine immune system
  229. Elderly at time of COronaVIrus disease 2019 (COVID-19): possible role ofย immunosenescenceย and malnutrition
  230. Impairment of gamma/delta T lymphocytes in elderly: implications forย immunosenescence
  231. The emerging role of ECM crosslinking in T cell mobility as a hallmark ofย immunosenescenceย in humans
  232. immunosenescenceย and herd immunity: with an ever-increasing aging population do we need to rethink vaccine schedules?
  233. CD56+ monocytes have a dysregulated cytokine response to lipopolysaccharide and accumulate in rheumatoid arthritis andย immunosenescence
  234. Factors associated withย immunosenescenceย during early adulthood in HIV-infected patients after durable efficient combination antiretroviral therapy
  235. Sepsis andย immunosenescence: closely associated in a vicious circle
  236. immunosenescenceย increases the rate of acceptance of kidney allotransplants in elderly recipients through exhaustion of CD4+ T-cells
  237. Signs of innate immune activation and prematureย immunosenescenceย in psoriasis patients
  238. Molecular and cellular bases ofย immunosenescence, inflammation, and cardiovascular complications mimicking โ€œinflammagingโ€ in patients with systemic lupus โ€ฆ
  239. Report from the second cytomegalovirus andย immunosenescenceย workshop
  240. immunosenescenceย and juvenile idiopathic arthritis
  241. Senescence-accelerated mice (SAMs) as a model for brain aging andย immunosenescence
  242. Aging and systemic lupus erythematosus-immunosenescenceย and beyond
  243. Inflammation, immune activation,ย immunosenescence, and hormonal biomarkers in the frailty-related phenotype of men with or at risk for HIV infection
  244. Obesity as a model of prematureย immunosenescence
  245. Associations between chronic caregiving stress and T cell markers implicated inย immunosenescence
  246. Zinc, metallothioneins andย immunosenescence
  247. immunosenescenceย study of T cells: a systematic review
  248. Increased T cellย immunosenescenceย and accelerated maturation phenotypes in older kidney transplant recipients
  249. Should we Try to Alleviateย immunosenescenceย and Inflammaging-Why, How and to What Extent?
  250. Aging,ย immunosenescenceย and membrane rafts: the lipid connection
  251. Protein nitration profile of CD3+ lymphocytes from Alzheimer disease patients: novel hints onย immunosenescenceย and biomarker detection
  252. Micronutrients that Affectย immunosenescence
  253. immunosenescenceย in the nursing home elderly
  254. Specific patterns of CD4โ€associatedย immunosenescenceย in vertically HIVโ€infected subjects
  255. Neuroendocrine and viral correlates of prematureย immunosenescence
  256. immunosenescenceย and gender: a study in healthy Cubans
  257. immunosenescenceย is associated with altered gene expression and epigenetic regulation in primary and secondary immune organs
  258. immunosenescence: participation of T lymphocytes and myeloid-derived suppressor cells in aging-related immune response changes
  259. Fromย immunosenescenceย to immune modulationโ€™: a re-appraisal of the role of cytomegalovirus as major regulator of human immune function
  260. Prematureย immunosenescenceย is associated with memory dysfunction in rheumatoid arthritis
  261. Lifelong exercise practice andย immunosenescence: Master athletes cytokine response to acute exercise
  262. Prematureย immunosenescenceย in HIV-infected patients on highly active antiretroviral therapy with low-level CD4 T cell repopulation
  263. Pharmacological advantages of melatonin inย immunosenescenceย by improving activity of T lymphocytes
  264. Down syndrome: is it really characterized by precociousย immunosenescence?
  265. Natural killer cellย immunosenescenceย in acute myeloid leukaemia patients: new targets for immunotherapeutic strategies?
  266. Impaired immune response in old mice suffering from obesity and prematureย immunosenescenceย in adulthood
  267. Endoplasmic reticulum stress caused by lipoprotein accumulation suppresses immunity against bacterial pathogens and contributes toย immunosenescence
  268. immunosenescence: the importance of considering age in health and disease
  269. Circulating T-cellย immunosenescenceย in Patients with Advanced Nonโ€“small Cell Lung Cancer Treated with Single-agent PD-1/PD-L1 Inhibitors or Platinum-based โ€ฆ
  270. Seasonal tradeโ€“offs in cellโ€“mediatedย immunosenescenceย in ruffs (Philomachus pugnax)
  271. Robustness and fragility inย immunosenescence
  272. Altered naive and memory CD4+ T-cell homeostasis andย immunosenescenceย characterize younger patients with myelodysplastic syndrome
  273. Targeting Inflammation andย immunosenescenceย to improve vaccine responses in the elderly
  274. Long-term culture of monoclonal human T lymphocytes: models forย immunosenescence?
  275. Hallmarks of Aging andย immunosenescence: Connecting the Dots
  276. Hyperbaric oxygen therapy increases telomere length and decreasesย immunosenescenceย in isolated blood cells: a prospective trial
  277. Aging andย immunosenescenceย in invertebrates
  278. immunosenescenceย and its influence on reproduction in a long-lived vertebrate
  279. immunosenescenceย and cancer vaccines
  280. Decreasing pro-inflammatory cytokine and reversing theย immunosenescenceย with extracts of Pu-erh tea in senescence accelerated mouse (SAM)
  281. Loss of CD127 & increasedย immunosenescenceย of T cell subsets in HIV infected individuals
  282. Do natural antibodies compensate for humoralย immunosenescenceย in tropical pythons?
  283. Reactive oxygen intermediate-induced pathomechanisms contribute toย immunosenescence, chronic inflammation and autoimmunity
  284. Acceleratedย immunosenescenceย in preindustrial twin mothers
  285. immunosenescenceย and mucosal immunity: significant effects of old age on secretory IgA concentrations and intraepithelial lymphocyte counts.
  286. HIV infection-related prematureย immunosenescence: high rates of immune exhaustion after short time of infection
  287. Avianย immunosenescence
  288. immunosenescence: potential causes and strategies for reversal
  289. The complex relationship betweenย immunosenescenceย and Inflammaging: Special issue on the New Biomedical Perspectives
  290. immunosenescenceย in renal transplantation: a changing balance of innate and adaptive immunity
  291. Zinc, metallothioneins andย immunosenescence: effect of zinc supply as nutrigenomic approach
  292. CD8+ย immunosenescenceย predicts post-transplant cutaneous squamous cell carcinoma in high-risk patients
  293. Association betweenย immunosenescenceย phenotypes and pre-frailty in older subjects: does cytomegalovirus play a role?
  294. Circulating T-cellย immunosenescenceย in Patients with Advanced Nonโ€“small Cell Lung Cancer Treated with Single-agent PD-1/PD-L1 Inhibitors or Platinum-based โ€ฆ
  295. Role of redox imbalance in the molecular mechanisms responsible forย immunosenescence
  296. The twilight of the immune system: The impact ofย immunosenescenceย in aging
  297. High perceived stress in women is linked to oxidation, inflammation andย immunosenescence
  298. Activation of cellular death programs associated withย immunosenescence-like phenotype in TPPII knockout mice
  299. Understandingย immunosenescenceย and its impact on vaccination of older adults
  300. immunosenescenceย and vaccination
  301. The unexpected contribution ofย immunosenescenceย to the leveling off of cancer incidence and mortality in the oldest old
  302. Cellularย immunosenescence: an overview
  303. Common variable immunodeficiency patients with a phenotypic profile ofย immunosenescenceย present with thrombocytopenia
  304. Effect of a synbiotic on the response to seasonal influenza vaccination is strongly influenced by degree ofย immunosenescence
  305. T-cell dysregulation caused by chronic antigenic stress: the role of CMV inย immunosenescence?
  306. Mitochondrial DNA damage in lymphocytes: a role inย immunosenescence?
  307. Probiotics as anti-immunosenescenceย agents
  308. Beneficial and detrimental effects of antiretroviral therapy on HIV-associatedย immunosenescence
  309. Homocysteine induces DNA damage and alterations in proliferative capacity of T-lymphocytes: a model forย immunosenescence?
  310. immunosenescenceย and the ability to survive bacterial infection in the red flour beetle Tribolium castaneum
  311. An inflammatory clock predicts multi-morbidity,ย immunosenescenceย and cardiovascular aging in humans
  312. The In Vitro Influence of a Genetic Superoxide-Hydrogen Peroxide Imbalance onย immunosenescence
  313. The influence and impact of ageing andย immunosenescenceย (ISC) on adaptive immunity during multiple sclerosis (MS) and the animal counterpart experimental โ€ฆ
  314. immunosenescence: a key player in cancer development
  315. Tumor Microenvironment-Regulatingย immunosenescence-Independent Nanostimulant Synergizing with Near-Infrared Light Irradiation for Antitumor Immunity
  316. immunosenescenceย profiles are not associated with muscle strength, physical performance and sarcopenia risk in very old adults: The Newcastle 85+ Study
  317. Cellularย immunosenescenceย in adult male crickets, Gryllus assimilis
  318. immunosenescence: clinical and pharmacologic considerations
  319. Regulation of autophagy as a therapy forย immunosenescenceโ€driven cancer and neurodegenerative diseases: The role of exercise
  320. MicroRNAs (MiRs) precisely regulate immune system development and function inย immunosenescenceย process
  321. Cytokine sensitivity of human NK cells duringย immunosenescence. 2. IL2-induced interferon gamma secretion
  322. Alzheimerโ€™s disease, neuroprotection, and CNSย immunosenescence
  323. Myocardial ischemia and reperfusion leads to transient CD8 immune deficiency and acceleratedย immunosenescenceย in CMV-seropositive patients
  324. Shifts in subsets of CD8+ T-cells as evidence ofย immunosenescenceย in patients with cancers affecting the lungs: an observational case-control study
  325. Effects of fish oil on HIV-related inflammation and markers ofย immunosenescence: a randomized clinical trial
  326. immunosenescenceย and age-related susceptibility to influenza virus in Japanese quail
  327. immunosenescenceย and vaccination of the elderly I. Age-related immune impairment
  328. Cellular basis ofย immunosenescence
  329. Update ofย immunosenescenceย in Cerebral Small Vessel Disease
  330. immunosenescenceย phenotypes in the telomerase knockout mouse
  331. Cellularย immunosenescence
  332. Do membrane rafts contribute to humanย immunosenescence?
  333. The innate immune system and aging: what is the contribution toย immunosenescence?
  334. immunosenescenceย induced by plasma from individuals with obesity caused cell signaling dysfunction and inflammation
  335. An immunological age index in bipolar disorder: A confirmatory factor analysis of putativeย immunosenescenceย markers and associations with clinical characteristics
  336. Age-relatedย immunosenescenceย in Fischer 344 rats: influence of exercise training
  337. Systematic expression profiling of innate immune genes defines a complex pattern ofย immunosenescenceย in peripheral and intestinal leukocytes
  338. Modulation of canineย immunosenescenceย by life-long caloric restriction
  339. Emergence of T cellย immunosenescenceย in diabetic chronic kidney disease
  340. Intestinal mucosalย immunosenescenceย in rats
  341. Ovariectomy causesย immunosenescenceย and oxi-inflamm-ageing in peritoneal leukocytes of aged female mice similar to that in aged males
  342. Cytomegalovirus drivenย immunosenescenceโ€”An immune phenotype with or without clinical impact?
  343. Chronic alcohol increases CD8+ T-cellย immunosenescenceย in simian immunodeficiency virus-infected rhesus macaques
  344. Growing old with the immune system: a study ofย immunosenescenceย in the zebra finch (Taeniopygia guttata)
  345. immunosenescenceย and Cancer Immunotherapy at Old Age: Basics
  346. Immunomodulatory role of high-density lipoproteins: impact onย immunosenescence
  347. Role of hormones in the regulation of RACK1 expression as a signaling checkpoint inย immunosenescence
  348. โ€ฆ Interleukin-6 (IL-6), and DHEA Inhibits IL-6 Secretion from Mononuclear Cells in Man in Vitro: Possible Link between Endocrinosenescence andย immunosenescence
  349. Characterization of intrinsic and extrinsic risk factors for celery allergy inย immunosenescence
  350. Insights into the role ofย immunosenescenceย during varicella zoster virus infection (shingles) in the aging cell model
  351. Effect of polysaccharides from a Korean ginseng berry on theย immunosenescenceย of aged mice
  352. Heterogeneity in thymic emigrants: implications for thymectomy andย immunosenescence
  353. Extracts of Cistanche deserticola can antagonizeย immunosenescenceย and extend life span in senescence-accelerated mouse prone 8 (SAM-P8) mice
  354. immunosenescenceย in persons with spinal cord injury in relation to urinary tract infections-a cross-sectional study
  355. Zinc, oxidative stress, genetic background andย immunosenescence: implications for healthy ageing
  356. Phosphoinositide 3-kinase inhibition restores neutrophil accuracy in the elderly: toward targeted treatments forย immunosenescence
  357. Horticultural Therapy Reduces Biomarkers ofย immunosenescenceย and Inflammaging in Community-Dwelling Older Adults: A Feasibility Pilot Randomized Controlled โ€ฆ
  358. Fasting, dietary restriction, andย immunosenescence
  359. Hallmarks of aging andย immunosenescence: Connecting the dots.
  360. โ€ฆ 1 cytokines within memory and effector/cytotoxic CD8+ T cells in humans: a contribution to understand the relationship between inflammation andย immunosenescence
  361. immunosenescence: implications for vaccination programs in the elderly
  362. New concepts on the pathogenesis of autoimmune diseases: a role for immune homeostasis, immunoregulation, andย immunosenescence
  363. Oxidative stress andย immunosenescenceย in spleen of obese mice can be reversed by 2โ€hydroxyoleic acid
  364. immunosenescenceย in testicular cancer survivors: potential implications of cancer therapies and psychological distress
  365. Immune activation,ย immunosenescence, and osteoprotegerin as markers of endothelial dysfunction in subclinical HIV-associated atherosclerosis
  366. Acupuncture for sleep quality, BDNF levels andย immunosenescence: a randomized controlled study
  367. Is chronic exposure to low-dose organochlorine pesticides a new risk factor of T-cellย immunosenescence?
  368. immunosenescenceย and immunotherapy in elderly acute myeloid leukemia patients: Time for a biology-driven approach
  369. Poor survival in glioblastoma patients is associated with early signs ofย immunosenescenceย in the CD4 T-cell compartment after surgery
  370. Gene expression changes in longโ€term culture of Tโ€cell clones: genomic effects of chronic antigenic stress in aging andย immunosenescence
  371. Preferential accumulation of mature NK cells during humanย immunosenescence
  372. T cell markers recount the course ofย immunosenescenceย in healthy individuals and chronic kidney disease
  373. immunosenescenceย in honey bees (Apis mellifera L.) is caused by intrinsic senescence and behavioral physiology
  374. The Paradigm ofย immunosenescenceย in Atherosclerosis-Cardiovascular Disease (ASCVD)
  375. Immunometabolism at the cornerstone of inflammaging,ย immunosenescence, and autoimmunity in COVID-19
  376. Tacklingย immunosenescenceย to improve COVID-19 outcomes and vaccine response in older adults
  377. A stochastic model for CD8+ T cell dynamics in humanย immunosenescence: implications for survival and longevity
  378. Compartmentalization ofย immunosenescence: a deeper look at the mucosa
  379. Decreased proportion of cytomegalovirus specific CD8 T-cells but no signs of generalย immunosenescenceย in Alzheimerโ€™s disease
  380. Juxtaposition of system dynamics and agent-based simulation for a case study inย immunosenescence
  381. Where Could Research onย immunosenescenceย Lead?
  382. Erosive pustular dermatosis: a manifestation ofย immunosenescenceย a report of 8 cases
  383. Evidence for less marked potential signs of T-cellย immunosenescenceย in centenarian offspring than in the general age-matched population
  384. The role of CMV inย immunosenescence
  385. A role for SKN-1/Nrf in pathogen resistance andย immunosenescenceย in Caenorhabditis elegans
  386. Lymphocyte modulation in a baboon model ofย immunosenescence
  387. Autoantibodies: innocent bystander or key player inย immunosenescenceย and atherosclerosis?
  388. Insect models ofย immunosenescence
  389. Why the elderly appear to be more severely affected by COVIDโ€19: the potential role ofย immunosenescenceย and CMV
  390. immunosenescence-like state is accelerated by constant light exposure and counteracted by melatonin or turmeric administration through DJ-1/Nrf2 and P53 โ€ฆ
  391. Overcoming the challenges ofย immunosenescenceย in the prevention of acute respiratory illness in older people.
  392. Detectable viral load aggravatesย immunosenescenceย features of CD8 T-cell subsets in vertically HIV-infected children
  393. immunosenescenceย in patients with chronic systolic heart failure
  394. Impact of cytomegalovirus on earlyย immunosenescenceย of CD8+ T lymphocytes after solid organ transplantation
  395. immunosenescenceย and human longevity
  396. Oxidative stress, inflammaging, andย immunosenescence
  397. The role of gender and labour status inย immunosenescenceย of 65+ Polish population
  398. Molecular and cell biological studies of ageing and their application to considerations of T lymphocyteย immunosenescence
  399. immunosenescenceย in chronic HIV infected patients impairs essential functions of their natural killer cells
  400. Interleukin-7 andย immunosenescence
  401. Hormones, genetic program andย immunosenescence.
  402. immunosenescenceย (iSenescence) correlates with disease progression in advanced non-small cell lung cancer (aNSCLC) patients treated with PD-(L) 1 inhibitors (IO โ€ฆ
  403. Childhood survivors of highโ€risk neuroblastoma show signs of immune recovery and notย immunosenescence
  404. immunosenescence
  405. Tโ€cell Immunoglobulin and ITIM Domain Contributes to CD8+ Tโ€cellย immunosenescence
  406. Zinc-binding proteins (metallothionein and ฮฑ-2 macroglobulin) andย immunosenescence
  407. Viruses andย immunosenescenceโ€“more players in the game
  408. immunosenescenceย and Respiratory Infections Among Nursing Home Residents
  409. Nutritional regulation ofย immunosenescenceย for heart health
  410. Mechanistic insights onย immunosenescenceย and chronic immune activation in HIV-tuberculosis co-infection
  411. Aging immunity,ย immunosenescence, or inflamm-aging: a comparative study of cytokines
  412. Cell Proliferation and Cell Death inย immunosenescenceย a
  413. A road to ruins: An insight intoย immunosenescence
  414. Acquired immunity:ย immunosenescenceย and physical activity
  415. immunosenescenceย in neurocritical care
  416. Review onย immunosenescence
  417. immunosenescenceย profile and expression of the aging biomarker (p16 INK4a) in testicular cancer survivors treated with chemotherapy
  418. Protein kinase C alpha-mediated chronic signal transduction forย immunosenescence.
  419. immunosenescence
  420. immunosenescenceย and vaccinations in the elderly
  421. immunosenescenceย and hurdles in the clinical management of older HIV-patients
  422. Prematureย immunosenescenceย in catecholamines syntesis deficient mice. Effect of social environment
  423. Are There Reliable Biomarkers forย immunosenescenceย and Inflammaging?
  424. The pathogenesis of age-related macular degeneration is not inflammatory mediated but is instead due toย immunosenescence-related failure of tissue repair
  425. Senile dementia, Alzheimer type: a distinct entity in theย immunosenescence?
  426. immunosenescenceย in a captive semelparous marsupial, the red-tailed phascogale (Phascogale calura)
  427. immunosenescenceย and vaccination of the elderly II. New strategies to restore age-related immune impairment
  428. Higher levels of osteoprotegerin and immune activation/immunosenescenceย markers are correlated with concomitant bone and endovascular damage in HIV โ€ฆ
  429. immunosenescenceย of the CD8+ T cell compartment is associated with HIV-infection, but only weakly reflects age-related processes of adipose tissue โ€ฆ
  430. A mathematical model for theย immunosenescence.
  431. immunosenescenceย Revisited
  432. A review of chronic kidney disease and the immune system: a special form ofย immunosenescence
  433. Nutritional zinc, oxidative stress andย immunosenescence: biochemical, genetic, and lifestyle implications for healthy ageing
  434. Nutrition as a Tool to Reverseย immunosenescence?
  435. Telomere-based therapy forย immunosenescence
  436. Opposing effects of cortisol and dehydroepiandrosterone on the expression of the receptor for activated C kinase 1: implications inย immunosenescence
  437. immunosenescenceย AND INFLAMM-AGEING.
  438. A new paradigm about HERV-K102 particle production and blocked release to explain cortisol mediatedย immunosenescenceย and age-associated risk of โ€ฆ
  439. Telomere length measurement and determination ofย immunosenescenceโ€related markers (CD28, CD45RO, CD45RA, interferonโ€ฮณ and interleukinโ€4) in skinโ€homing โ€ฆ
  440. Functional analysis of theย immunosenescenceย of the human B cell system: dissociation of normal activation and proliferation from impaired terminal differentiation into โ€ฆ
  441. Socio-economic status andย immunosenescence
  442. immunosenescenceย and CoQ10
  443. The effects of aging and maternal protein restriction during lactation on thymic involution and peripheralย immunosenescenceย in adult mice
  444. MtmRNA gene expression, via IL-6 and glucocorticoids, as potential genetic marker ofย immunosenescence: lessons from very old mice and humans
  445. T cellย immunosenescence, hypertension, and arterial stiffness
  446. Theย immunosenescence.
  447. immunosenescenceย of human NK cells: effects on tumor target recognition, lethal hit and interferon sensitivity
  448. T cellย immunosenescence
  449. immunosenescence: Mechanisms, Clinical Impacts, and Therapeutic Strategies
  450. HIV and aging as a model forย immunosenescence
  451. Injection of T-cell receptor peptide reducesย immunosenescenceย in aged C57BL/6 mice.
  452. Signal transduction mechanisms in the immune system: potential implication inย immunosenescence
  453. immunosenescence, oxidative stress, and cancers
  454. immunosenescenceย and SARS-CoV-2 Vaccine Development
  455. Chronic antigenic stress,ย immunosenescenceย and human survivorship over the 3 last centuries: heuristic value of a mathematical model
  456. Noni (Morinda citrifolia L.) fruit juice delaysย immunosenescenceย in the lymphocytes in lymph nodes of old F344 rats
  457. Nonhuman Primate Models ofย immunosenescence
  458. immunosenescenceย and senescence immunosurveillance: one of the possible links explaining the cancer incidence in ageing population
  459. immunosenescence: immune deficits in the elderly and therapeutic strategies to enhance immune competence
  460. Role of some selected Bifidobacterium strains in modulatingย immunosenescenceย of aged albino rats
  461. Role of zinc and selenium in oxidative stress andย immunosenescence: implications for healthy ageing and longevity
  462. Proceedings of a symposium on โ€œimmunosenescenceโ€”a major cause of disease in the elderly: from molecules to patientsโ€: Summary
  463. immunosenescenceย does not abrogate engraftment of murine allogeneic bone marrow
  464. immunosenescenceย and its potential modulation: lessons from mouse models
  465. Immune system aging may be affected by HIV infection: the mathematical model ofย immunosenescence
  466. Flagellinโ€dependent TLR 5/caveolinโ€1 as a promising immune activator inย immunosenescence
  467. Glucocorticoids and Dehydroepiandrosterone: A Role inย immunosenescence?
  468. Castration reversesย immunosenescenceย in aged mice
  469. Cellularย immunosenescenceย in F344 rats: Decline in responsiveness to phytohemagglutini involves changes in both T cells and macrophages
  470. Skinย immunosenescence: decreased receptor for activated C kinaseโ€1 expression correlates with defective tumour necrosis factorโ€ฮฑ production in epidermal cells
  471. TNFฮฑ polymorphism as marker ofย immunosenescenceย for rheumatoid arthritis patients
  472. Kaposiโ€™s sarcoma in a treated and well-controlled HIV infected patient: Discussion on the role ofย immunosenescence
  473. Aging,ย immunosenescence, and Cancer
  474. Prematureย immunosenescence: a pathogenetic factor in Alzheimerโ€™s disease?
  475. SARS-CoV-2,ย immunosenescenceย and inflammaging: partners in the COVID-19 crime
  476. Is Aging andย immunosenescenceย a Risk Factor For Dimethyl Fumarate Induced PML?(P2. 088)
  477. immunosenescence, Inflammaging, and Their Implications for Cancer and Anemia
  478. Prematureย immunosenescenceย impairs immune surveillance allowing the endometriotic stem cell to migrate: The cytokine profile as a common denominator
  479. immunosenescence
  480. Sex hormones andย immunosenescence
  481. Role ofย immunosenescenceย in infections and sepsis in the elderly
  482. immunosenescence-inevitable or preventable?: review articles
  483. Liver fibrosis and accelerated immune dysfunction (immunosenescence) among HIV-infected Russians with heavy alcohol consumption-an observational โ€ฆ
  484. Spontaneous HIV controllers might be the key to prevent acceleratedย immunosenescenceย of effector CD8+ T cells
  485. โ€ฆ progression and robust innate host response in aged SIVmac239-infected Chinese rhesus macaques is associated with enhancedย immunosenescence
  486. Immune System,ย immunosenescenceย and Immunisation in the Elderly
  487. immunosenescenceย and the gut microbiota: the role of probiotics and prebiotics
  488. Nutraceuticals inย immunosenescence
  489. The somatotrope growth hormone-releasing hormone/growth hormone/insulin-like growth factor-1 axis in immunoregulation andย immunosenescence
  490. immunosenescence
  491. Chronic viral infections andย immunosenescence, with a focus on CMV
  492. Somatotrope GHRH/GH/IGF-1 axis at the crossroad betweenย immunosenescenceย and elder frailty
  493. Diet andย immunosenescence
  494. Rejuvenation of mucosalย immunosenescenceย by adipose tissue-derived mesenchymal stem cells
  495. Handbook onย immunosenescence: Basic Understanding and Clinical Applications
  496. Cellularย immunosenescenceย in F344 rats: decreased natural killer (NK) cell activity involves changes in regulatory interactions between NK cells, interferon โ€ฆ
  497. immunosenescence-the role in the immunotherapy of older population.
  498. Cancer, Ageing andย immunosenescence
  499. immunosenescence: implications for cancer immunotherapy in elderly patients
  500. HIV dynamics andย immunosenescence
  501. Breast cancer andย immunosenescence
  502. The influence ofย immunosenescenceย on tumor growth and spread: lessons from animal models.
  503. Melatonin and tryptophan as therapeutic agents against the impairment of the sleep-wake cycle andย immunosenescenceย due to aging in Streptopelia risoria
  504. immunosenescenceย in Montecatini
  505. immunosenescenceย of the human B cell system: impaired activation/proliferation in response to autologous monocytes pulsed with Staph protein A and the effects of โ€ฆ
  506. immunosenescenceย and the ageing lung
  507. immunosenescenceย (iSenescence) correlates with progression (PD) to PD-(L) 1 inhibitors (IO) and not to platinum-chemotherapy (PCT) in advanced non-small cell โ€ฆ
  508. โ€ฆ -MS ProteinChip array profiling of T-cell clones propagated in long-term culture identifies human profilin-1 as a potential bio-marker ofย immunosenescence
  509. Clinical and experimental study on retardation ofย immunosenescenceย by kidney tonifying principle
  510. Post-thymic CD4 positive cytotoxic T cell infiltrates of the skin: A clinical and histomorphologic spectrum of the unique CD4 positive T cell ofย immunosenescence
  511. Effects of Heavy Drinking on Tโ€Cell Phenotypes Consistent withย immunosenescenceย in Untreated HIV Infection
  512. Current status and future prospects in the search for protein biomarkers ofย immunosenescence
  513. CD57+, a global marker ofย immunosenescence, is elevated in an atypical cohort of patients with Kaposi sarcoma and well-controlled HIV
  514. Markers of prematureย immunosenescenceย in the peripheral blood of multiple sclerosis subjects vs. healthy controls
  515. Impaired immunity and increased risk of infections in older adults: impact of chronic disease onย immunosenescence
  516. Biological and chronological age in heart failure: role ofย immunosenescence
  517. immunosenescenceย and its role in cancer
  518. Coronavirus Disease (COVID-19): A Perspective fromย immunosenescence
  519. immunosenescence: ageing of the immune system
  520. immunosenescenceย in horses
  521. immunosenescenceย and late life depression
  522. Pandemic influenza H1N1 2009, innate immunity, and the impact ofย immunosenescenceย on influenza vaccine
  523. Investigation of D-galactose Induced Cellular and Organicย immunosenescenceย [J]
  524. Neutrophil ageing andย immunosenescence
  525. Modeling ofย immunosenescenceย and Risk of Death from Respiratory Infections: Evaluation of the Role of Antigenic Load and Population Heterogeneity
  526. A theoretical model forโ€™in machinaโ€™: Experiments onย immunosenescence
  527. Role of TLR polymorphisms inย immunosenescence
  528. immunosenescenceย of CD4+ T cells in male homosexual patients with HIV-1 infection
  529. immunosenescence: What is It and What Can Be Done About It?
  530. Effect ofย immunosenescenceย on the induction of cardiovascular disease pathogenesis: role of peripheral blood mononuclear cells
  531. The role of stress and adrenal hormones inย immunosenescence
  532. Perspectives: isย immunosenescenceย clinically relevant?
  533. immunosenescence-related Markers of T Cell Subsets in Conventional Lymphocyte Immunophenotyping
  534. Mechanisms ofย immunosenescenceย Short report
  535. Exercise, Sarcopenia andย immunosenescence
  536. T Cell-mediated immunity in theย immunosenescenceย process
  537. HIV infection as a model of acceleratedย immunosenescence
  538. Lifestyle Exercise Attenuatesย immunosenescence; Flow Cytometry Analysis
  539. Cytokine polymorphisms andย immunosenescence
  540. Insulin resistance, chronic inflammation and the link withย immunosenescence
  541. Imagingย immunosenescence
  542. Zinc, aging, andย immunosenescence: an overview
  543. UNDERSTANDING AND ADDRESSINGย immunosenescence
  544. Basic biology and clinical impact ofย immunosenescence
  545. Inhibition of Fasโ€mediated apoptotic cell death of murine T lymphocytes in a mouse model ofย immunosenescenceย in linkage to deterioration in cell membrane raft โ€ฆ
  546. Proteasome activity andย immunosenescence
  547. immunosenescenceย of Lymphocytes T and Implications for Age-Related Disorders
  548. Mucosal Vaccines for Aged: Challenges and Struggles inย immunosenescence
  549. immunosenescenceย in rheumatoid arthritis: Use of CD28 negative T cells to predict treatment response
  550. Effects ofย immunosenescenceย on the Lower Expression of Surface Molecules in Neutrophils and Lymphocytes
  551. Update of skinย immunosenescenceย in geriatric population
  552. Glucocorticoids and DHEA: Do they have a role inย immunosenescence?
  553. Antibody repertoire sequencing reveals systemic and mucosalย immunosenescenceย in the short-lived turquoise killifish
  554. immunosenescence: analysis and genetic modulation of replicative senescence in T cells
  555. immunosenescence: A Study in Healthy Elderly Population
  556. immunosenescenceย modulation by vaccination
  557. Age-Independentย immunosenescence: An Antigen-Activated, Sexually Dimorphic Program Predicts Inflammation of Aging and HIV-1 Susceptibility
  558. UNDERSTANDING AND ADDRESSINGย immunosenescence
  559. Cancer-associated imโ€mune deficiency: A form of acceleratedย immunosenescence
  560. Mathematical modeling ofย immunosenescence: scenarios, processes and limitations
  561. The role of microRNAs inย immunosenescenceย process
  562. immunosenescenceย and Cutaneous Malignancies
  563. immunosenescenceย and nutrition: reviewing clinical evidence on pre-, pro-and synbiotics in aging
  564. โ€ฆ healthspan and lifespan in mice by mitigating multiple aspects of cellular senescence in mitotic and post-mitotic tissues, gut dysbiosis andย immunosenescence
  565. Cultured T cell clones as models forย immunosenescence
  566. Apoptosis andย immunosenescence
  567. immunosenescenceย and Aging
  568. Centenarians overexpress BCL-xL, which confers them a protection against apoptosis, oxidative stress andย immunosenescence
  569. Dendritic cells inย immunosenescence
  570. Cellular Response to Stress: At the Crossroads betweenย immunosenescenceย and Cancer
  571. Fructus Lycii influence investigation to thymus function in D-galactose inducedย immunosenescenceย mouse model [J]
  572. Study of T Cellย immunosenescenceย in Various Tissue Compartments
  573. Prematureย immunosenescenceย in triple-transgenic mice for Alzheimerโ€™s disease
  574. Growth differentiation factor-15 is associated with age-related monocyteย immunosenescence
  575. Does chronic caregiving stress accelerate T cellย immunosenescence?
  576. immunosenescence
  577. Immunological analysis of myeloid derived suppressor cell (MDSC): Osteoclast differentiation andย immunosenescence
  578. Innateย immunosenescenceย and its impact on health in old age
  579. Transgenic mouse models forย immunosenescence
  580. immunosenescence.
  581. Correlation research onย immunosenescenceย and cells of the innate immune system
  582. immunosenescenceย and the 3Rs: Restoration, Replacement and Reprogramming
  583. immunosenescence: More research is needed
  584. A Matter of Life and Death of T-Lymphocytes inย immunosenescence
  585. Zinc-Binding Proteins andย immunosenescence: Implications as Biological and Genetic Markers
  586. Exercise andย immunosenescence
  587. immunosenescence, thymic involution and autoimmunity
  588. Obesity andย immunosenescence: Psychological, Behavioral and Biochemical Pathways
  589. immunosenescence: The Forefront of Infection and Trophic Control
  590. immunosenescenceย and Physical Exercise Intervention: For the Prevention of Senile Disease
  591. The characteristic of immunity in long-lived persons and selection of theย immunosenescenceย markers
  592. SENIEUR status of the originating cell donor negates certain โ€˜anti-immunosenescenceโ€˜effects of ebselen and N-acetyl cysteine in human T cell clone cultures
  593. immunosenescence-the sunset over the immune system.
  594. IL-7 concentration is increased in nonagenarians but is not associated with markers of T cellย immunosenescence
  595. EVALUATION OF THE BASELINE CHARACTERISTICS ANDย immunosenescenceย OF BLOOD LYMPHOCYTES AMONG ELDERLY HIV-INFECTED PATIENTS IN โ€ฆ
  596. A discrete HIV infection model withย immunosenescence
  597. Erratum to Zinc, infections andย immunosenescence-(Mech. Ageing Develop. 121 (2000) 21-35)
  598. Understandingย immunosenescenceย in Aging-Related Diseases With Quantitative Proteomics
  599. Signs ofย immunosenescenceย in patients diagnosed with non-small cell lung cancer
  600. immunosenescenceย and infectious diseases
  601. Strategies to overcome the age-old problem ofย immunosenescence
  602. ฤฐmmunosenescence and The ฤฐmportance of ฤฐnfluenza and Pneumococcal Vaccine in Elderly?
  603. immunosenescenceย and human NK cells
  604. Natural killer cellย immunosenescenceย and cancer in the elderly
  605. Inflammation and neutrophilย immunosenescenceย in health and disease
  606. The evolution of avian lifespan: an examination of telomere dynamics andย immunosenescence
  607. Progressiveย immunosenescenceย in diabetic chronic kidney disease
  608. UNDERSTANDINGย immunosenescence, LIFE-SPAN IMMUNIZATION, AND NOVEL PREVENTIVE OPTIONS
  609. Precision Medicine: Focus on Age-independentย immunosenescence
  610. Comparative Study onย immunosenescenceย Modulation Effect of Tonifying Kidney Removing Blood Stasis and Tonifying Kidney Invigorating Spleen Removing Blood โ€ฆ
  611. Oxidative stress andย immunosenescence
  612. A study of cytomegalovirus infection, cognitive ability andย immunosenescenceย in older adults
  613. immunosenescenceย in Type 2 Diabetic Patients with Chronic Renal Disease
  614. immunosenescence: delayed cutaneous hypersensitivity tests in independently-living Chilean elderly individuals
  615. IMPACT OF OBSTRUCTIVE SLEEP APNOEA AND TREATMENT RESPONSE ONย immunosenescenceย PARAMETERS IN HYPERTENSION
  616. Regulating effect and mechanism of electroacupuncture with shuanggu yitong prescription methods onย immunosenescenceย in aging rats with yang deficiency
  617. Effects of aging onย immunosenescenceย and checkpoint inhibitor efficacy in a C57BL/6J syngeneic model
  618. immunosenescenceย and Host-Pathogen Relationships: The example of Influenza
  619. Clinical relevance ofย immunosenescence
  620. ADJUVANTED VACCINES TO ADDRESSย immunosenescenceย AND PROMOTE HEALTH THROUGHOUT LIFE
  621. Immune system changes andย immunosenescence
  622. immunosenescenceย in HIV infection
  623. The Impact of Diet onย immunosenescence
  624. immunosenescenceย and the importance of age in risk stratification of progressive multifocal leukoencephalopathy (P2. 318)
  625. immunosenescenceย and cancer immunotherapy.
  626. The ageing immune system: can physical activity ameliorateย immunosenescenceย and thereby reduce age-related multi-morbidity?
  627. immunosenescenceย under an evolutionary perspective
  628. Exaggerated neutrophilย immunosenescenceย in sepsis and its potential modification with simvastatin
  629. New Advances in CMV andย immunosenescence
  630. As time goes byโ€ฆ Would CD4+ T cells depletion induce earlyย immunosenescenceย in HIV infected patients?
  631. Hyperactive cytokine T-cell response is associated withย immunosenescenceย in severe acute COVID-19 infection
  632. Evidence forย immunosenescenceย in natural populations.
  633. immunosenescenceย and gender: a study in healthy Cubans.
  634. HORMONES, GENETIC PROGRAM ANDย immunosenescence
  635. immunosenescenceย and Its Aplications to Artificial Immune Systems
  636. Resistance training andย immunosenescenceย of the innate immune system
  637. Mouse Models and Genetics ofย immunosenescence
  638. Mitochondria andย immunosenescence
  639. Effects of serums containing Buzhong Yiqi decoction with Astragalus Radix or Hedysari Radix on anti-immunosenescenceย in spleen lymphocytes of SAMP8 mice
  640. Challenges of vaccination in older people. Can we circumventย immunosenescence?
  641. immunosenescenceย and exercise-mediated modulation of the innate immune response to Influenza infection in mice
  642. T cellย immunosenescenceย is associated with the presence of Kaposiโ€™s sarcoma in antiretroviral treated human immunodeficiency virus-infected persons
  643. immunosenescence: the reason older adults are more vulnerable to viruses, and how to prevent itโ€“Part
  644. A transgenic dwarf rat strain as a tool for the study ofย immunosenescenceย in aging rats and the effect of calorie restriction
  645. immunosenescenceย and vaccination in the elderly [J]
  646. Exercise Training andย immunosenescence
  647. Correlational Research ofย immunosenescenceย and the Change of T, B Cell
  648. Markers ofย immunosenescenceย in the peripheral blood of multiple sclerosis subjects compared to healthy controls
  649. AGING TREATMENT BY COUNTERACTING INTRINSIC DNA DAMAGE ANDย immunosenescence
  650. Characterization of human plasma extracellular vesicles and their role in aging-relatedย immunosenescenceย and immune response
  651. Nonpharmacologic therapeutic possibilities forย immunosenescence
  652. Effects of mTOR Inhibition onย immunosenescenceย in the Elderly
  653. Zinc-binding proteins (metallothionein and ฮฑ-2 macroglobulin) as potential biological markers ofย immunosenescence
  654. Can Nutritional Intervention Counteractย immunosenescenceย in the Elderly?
  655. Associations of Cytokine Polymorphisms withย immunosenescence
  656. Involvement ofย immunosenescenceย in the frailty syndrome (85.13)
  657. Molecular Mechanisms of Compromised B-Cell Functions Duringย immunosenescence.: Abstract# D2336
  658. Investigation of Molecular Mechanisms Involved in Retardation ofย immunosenescenceย in Caenorhabditis elegans by Royal Jelly
  659. THE IMPACT OFย immunosenescenceย ON THE IMMUNE RESPONSES: A CHALLENGE ON INFLUENZA VACCINATION IN THE ELDERLY
  660. AB0050ย immunosenescenceย of T and B cells in systemic sclerosis
  661. Human Cytomegalovirus as a driving force towardsย immunosenescence
  662. Insights into the role ofย immunosenescenceย during varicella zoster virus infection (shingles) in the aging cell model
  663. Influenza virus vaccine adjuvant dominant inย immunosenescence
  664. Pharmacological advantages of melatonin inย immunosenescenceย by improving activity of T lymphocytes
  665. P1. 01-18ย immunosenescenceย Correlates with Progression upon PD-(L)-1 Blockade (IO) in Advanced Non-Small Cell Lung Cancer (aNSCLC) Patients
  666. Transcription Factors and Checkpoint Inhibitor Expression with Age: Markers ofย immunosenescence?
  667. Abnormal regulation of T lymphocytes from aged rats contributes toย immunosenescence
  668. Genes, Hormones,ย immunosenescence, and Environmental Agents: Toward an Integrated View of the Genesis of Autoimmune Disease
  669. Comparative Studies of Single Gene to Genes Groups on the Kidney Tonifying Method in Regulatingย immunosenescence
  670. Fat-rich diet-induced obese mice show prematureย immunosenescence
  671. Epigenetics andย immunosenescenceย Reversal: An Evidence-Based Longevity Paradigm
  672. Erratum: Common Variable Immunodeficiency patients with a phenotypic profile ofย immunosenescenceย present with thrombocytopenia
  673. Corrigendum: Modulation of gut microbiota and delayedย immunosenescenceย as a result of syringaresinol consumption in middle-aged mice
  674. P-glycoprotein expression in murine T lymphocytes: Implications for development, function, andย immunosenescence.
  675. Metabolomic Profile of Human Serum to Determine the Age Relatedย immunosenescence
  676. Corrigendum to โ€˜Immunologic mechanisms of fingolimod and the role ofย immunosenescenceย in the risk of cryptococcal infection: A case report and review of literatureโ€™ โ€ฆ
  677. Insight into the role ofย immunosenescenceย during varicella zoster virus infection (shingles) in the aging cell model
  678. Effects ofย immunosenescenceย on professional antigen presenting cell immunogenicity in the context of Varicella zoster viral infection (APP3P. 114)
  679. immunosenescence: Telomere and telomerase dynamics in human T cells.
  680. The influence ofย immunosenescenceย on cancer immunotherapy: Cellular mechanisms of immunotherapy against the Lewis lung carcinoma with biological response โ€ฆ
  681. ROLE OFย immunosenescence, FRAILTY, CMV AND VACCINE DOSE IN IMMUNE RESPONSES TO INFLUENZA VACCINATION
  682. Theย immunosenescenceย of Cytolytic T Lymphocytes (CTL): Reduction of Pore-Forming Protein and Granzyme Levels
  683. โ€ฆ life stress and perinatal glucocorticoid exposure produce complex immune system alterations, including accelerated T cellย immunosenescence, in adolescent rhesus โ€ฆ
  684. Clinical Trials and Observations: Early-onset Evans syndrome, immunodeficiency, and prematureย immunosenescenceย associated with tripeptidyl-peptidase II โ€ฆ
  685. Altered Naive and Memory T Cell Homeostasis andย immunosenescenceย Characterize Younger Patients with Immunosuppressive-Responsive Myelodysplastic โ€ฆ
  686. 406 Isย immunosenescenceย infectious?
  687. Acceleratedย immunosenescence, the glial S100B protein and error-monitoring in remitted depression: A study to identify new candidates for state markers of โ€ฆ
  688. PS 17-15 THE RELATIONSHIP BETWEEN OBSTRUCTIVE SLEEP APNEA ANDย immunosenescenceย IN HYPERTENSIVE PATIENTS
  689. Omega-3 Polyunsaturated Fatty Acids andย immunosenescence
  690. โ€ฆ lymphocytes in three age categories of luminal B-like breast cancer patients and its correlation with lymph node involvement and systemicย immunosenescence/frailty โ€ฆ
  691. GROWTH DIFFERENTIATION FACTOR 15 IS CORRELATED TO MARKERS OFย immunosenescenceย IN MONOCYTES
  692. 177.ย immunosenescenceย is associated with disease progression but not depression in presymptomatic stage B heart failure patients
  693. KS-1ย immunosenescenceย in Critical Care
  694. 677 Older Patients with Hemodynamic Compromise Rejection: What Happened toย immunosenescence?
  695. โ€ฆ into the binding of CLEC-2 platelets with podoplanin under flow and Comparing the cell intrinsic and environmental effects ofย immunosenescenceย on B cell response
  696. OS 01-08 IMPACT OF HYPERTENSION TREATMENT ONย immunosenescenceย PARAMETERS
  697. Phosphoinositide 3-kinase inhibition restores neutrophil accuracy in the elderly: toward targeted treatments forย immunosenescence

Mandatory FDA Disclaimer: Not intended to diagnose, treat, cure or prevent any disease.

Mandatory FDA Disclaimer: Not intended to diagnose, treat, cure or prevent any disease.

0
    0
    Your Cart
    Your cart is emptyReturn to Shop